GRTX - Galera Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Galera Therapeutics's activity chart (see below) currently has 20 price targets and 35 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 78.33% with an average time for these price targets to be met of 948.5 days.

Most recent stock forecast was given by YIGAL NOCHOMOVITZ from CITI on 29-Aug-2023. First documented stock forecast 02-Dec-2019.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 29-Aug-2023

$0.25

$-16.03 (-98.46%)

3 years 17 days ago
(29-Aug-2023)

1/5 (20%)

$0.04 (19.05%)

50

Buy Since 16-Dec-2021

$0.3

$-15.98 (-98.16%)

$6

3 years 30 days ago
(16-Aug-2023)

4/4 (100%)

$0.05 (20.00%)

1352

Buy Since 21-Feb-2023

$0.5

$-15.78 (-96.93%)

$6

3 years 1 months 5 days ago
(10-Aug-2023)

2/2 (100%)

$0.14 (38.89%)

1153

Buy Since 02-Dec-2019

$7

$-9.28 (-57.00%)

3 years 6 months 30 days ago
(16-Feb-2023)

3/3 (100%)

$5.41 (340.25%)

430

Hold Since 14-Dec-2021

$15

4 years 8 months 30 days ago
(16-Dec-2021)

1/2 (50%)

$12.3 (455.56%)

1672

Show more analysts

Please expand the browser size to see the chart

What is GRTX (Galera Therapeutics) average time for price targets to be met?

On average it took 949 days for the stock forecasts to be reached, with an average price target met ratio of 78.33%.

Which analyst most recently updated their price target on GRTX (Galera Therapeutics)?

Yigal Nochomovitz

Which analyst has the current lower performing score on GRTX (Galera Therapeutics) with a proven track record?

ROBERT HAZLETT

Which analyst has the most public recommendations on GRTX (Galera Therapeutics)?

Yigal Nochomovitz works at CITI and has 3 price targets and 2 ratings on GRTX

Which analyst is the currently most bullish on GRTX (Galera Therapeutics)?

Robert Hazlett with the highest potential upside of $0

Which analyst is the currently most reserved on GRTX (Galera Therapeutics)?

Yigal Nochomovitz with the lowest potential downside of -$16.03

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?